Objective: The ideal combination of premedication for neonatal tracheal intubation has not been established. The aim of this preliminary study was to compare the intubation conditions between propofol and midazolam as premedication for tracheal intubation in neonates.
Introduction
Endotracheal intubation of premature neonates is performed frequently in the Neonatal Intensive Care Units and delivery rooms. The procedure is associated with physiological and biochemical responses, and now there are strong evidences that premedication (sedation and analgesia) improves the physiological stability, decreases the time and difficulty of the procedure, and also reduces the potential for airway injury. 1 Remifentanil has been considered a good option for premedication 2, 3 and it has been used even in the InSurE procedure. 4 Silva et al. 2 considered that morphine when compared with remifentanil was not the best choice owing to its delayed onset of action.
The necessity to associate a hypnotic drug to a regimen of premedication for tracheal intubation is based on the contemplation of the requirement to give hypnosis, amnesia and sedation besides analgesia and, moreover, on the fact that most opioids in the normal range of doses used as premedication do not produce enough sedation and no amnesia at all. 5 This observation is also supported by recent studies which postulate that 'newborn infants display features characteristic of what may be referred to as basic or minimal consciousness'. 6, 7 To guarantee hypnosis during premedication for tracheal intubation, midazolam has been used in the majority of the Neonatal Intensive Care Units, 1 although concerns and restrictions on its use have emerged in the literature. 8, 9 In this context, propofol could have theoretical and practical advantages (fast onset and offset of action) over other hypnotic drugs, making it appropriate in attenuating the overall stimuli related to laryngoscopy and intubation. 10 The aim of this preliminary randomized double-blinded study was to compare both hypnotics propofol versus midazolam in association with remifentanil for tracheal intubation of preterm neonates with respiratory distress syndrome, in order to detect whether any of these combinations could provide a better intubation condition, which would be of clinical importance.
Patients and methods
This preliminary study included 20 premature neonates (28 to 34 week) admitted to two tertiary Neonatal Intensive Care Units, which required an elective tracheal intubation to treat respiratory failure from respiratory distress syndrome. The Ethics Committees of both institutions have approved the study and an informed consent was obtained from the parents of all selected subjects. An equal number of neonates (n ¼ 10) were randomized to each study group using a random number table. Patients were excluded if they had major congenital malformations; birth weigh <1000 g; previous or concurrent use of opioid or hypnotic drugs; previous intubation at any time; seizures before entering the protocol; Apgar score at 5 minutes of <7; or hemodynamic instability before intubation.
Following randomization and enrollment, patients sequentially received an intravenous bolus injection over 1 minute of either midazolam 200 mg kg À1 and remifentanil 1 mg kg À1 or propofol 2 mg kg À1 and remifentanil 1 mg kg À1 (in this sequence), followed by 2 ml of normal saline infusion over 30 s. The medications were done through an exclusive venous access (umbilical vein access). Intubation was done 120 s after the remifentanil dose. Two pharmacists (one from each hospital) received a binder containing the sequence of treatment group and they also ensured that the two preparations could not be differentiated (covering the entire venous line and syringes with a special aluminum foil).
The patients were submitted to pre-oxygenation with 100% oxygen, and a monitor DX 2010 LCD (DIXTAL Biomédica Ind. Com. Ltda., Manaus, Brazil) recorded the heart rate (HR), blood pressure and oxygen saturation. A single neonatologist blind to the study protocol performed all intubations and classified its conditions as excellent, good or poor.
11 Intubation conditions were also scored based on a four-point scale according to the ease of laringoscopy, position of vocal cords, coughing, jaw relaxation and movement of the limbs. 11 Each tracheal intubation attempt required <20 s.
Blood pressure, HR and oxygen saturation were recorded before, during and for a period until 6 h after the intubation. Hypotension was defined as mean arterial pressure <25 mm Hg; bradycardia as HR <100 b.p.m. and desaturation as oxygen saturation <85% in the first hours of life. The pain and stress were assessed before, during and after the intubation using the neonatal infant pain scale (NIPS) 12 and the COMFORT scale, 13 respectively, which include physiological and behavioral parameters.
A sample size of 10 in each group would be enough to detect a change of 50% among the quality of intubation between both groups, with a power of 80% and a significant level (alpha) of 0.05 (two-tailed).
The Shapiro-Wilk test was used to check the normal distribution of the data in the study. Student's t-test, Fisher's exact test, Mann-Whitney U-test and Wilcoxon-Mann-Whitney test were used when appropriate. One-way analysis of variance for repeated measures was used for parametric data, followed by post hoc multiple comparisons with Student-Newman-Keuls test. A P-value below 0.05 was considered significant.
Results
There were no differences in demographic characteristics of the study population (Table 1) . None had acute asphyxia and none were receiving non-opioid or hypnotic sedation drugs. All neonates were in nasal continuous airway pressure therapy before intubation, with similar ventilatory parameters and degree of respiratory distress syndrome. Table 2 shows that excellent conditions to intubate were observed in only three neonates that received midazolam and in four patients who received propofol (P ¼ 1.00). A second attempt to intubate was necessary in three patients infused with midazolam and in two patients infused with propofol (P ¼ 1.00).
Considering the specific intubation conditions according to the score used, there were no differences among the parameters evaluated (Table 3) .
No statistical differences were observed as well between the drugs regarding pain and stress level before and after the intubation using the NIPS scale (before intubation P ¼ 0.585; after intubation P ¼ 1.00) and the COMFORT scale (before intubation P ¼ 0.140; after intubation P ¼ 0.331). But both combinations of drugs were capable of analgesia and sedation according to NIPS and COMFORT scores, when comparing the scores before and after intubation in each separate group (data not shown).
Considering the hemodynamic variables (blood pressure and HR), there were no differences between the groups before the infusion of the drugs, after intubation and during the first 60 min after intubation (Figure 1) , and the same is for oxygen saturation (data not shown).
Adverse effects like cutaneous rash (one in propofol group), difficulty to ventilate the baby (two in the propofol and one in Propofol versus midazolam for intubating neonates MG Penido et al midazolam group), hypotension (two in each group) and bradycardia (one in propofol group), as defined before, were seen at some time after the infusion of the drugs, but without further complications.
Discussion
Tracheal intubation is an extremely stressful and painful procedure; however, unfortunately, the use of premedication in neonates is not a worldwide routine. Awake intubation in this population is associated with adverse physiological responses, 14 which could be attenuated by premedication.
1,5,15
The ideal agent or combination of agents for premedication should be easy to administer, and it should provide excellent intubation conditions with minimal side effects. 14 The best combination of drugs should contemplate a potent analgesic, a hypnotic drug and sometimes also a neuromuscular blocking agent. However, there is no consensus about the drug, combination of drugs or doses for premedication mainly regarding tracheal intubation in Neonatal Intensive Care Units. 1, 5, 9, 14, 16 The findings of this preliminary study didn't show any difference in the quality of intubation, presence of adverse effects, changes on the hemodynamic variables, and in the quality of sedation and analgesia achieved when midazolam or propofol was used as hypnotic associated with remifentanil as premedication for tracheal intubation in preterm neonates (28 to 34 weeks gestation).
Propofol has become popular as an anesthetic agent in young children, but like other hypnotics, is has not been extensively studied as premedication in neonates and has not been used routinely in the neonatal population. 10 Propofol is a hypnotic drug with no analgesic effect. The time of onset is within minutes and although the half-life is measured in hours, the extent of clinical activity is measured in minutes because the agent is distributed quickly to peripheral tissues. The pharmacokinetics of propofol in neonates was studied in 25 neonates (10 pretermsF26 to 37 weeks) after a bolus injection of 3 mg kg À1 . The authors found that there may be an interindividual variability of propofol clearance in this population, and it could be influenced by postmenstrual and postnatal age. 17 In a controlled, open label study, 63 infants were randomized to receive propofol (2.5 mg kg À1 ; n ¼ 33) or a combination of succinylcoline (2 mg kg À1 ), morphine (0.1 mg kg À1 ) and atropine (0.01 mg kg
À1
; n ¼ 30) before tracheal intubation. Propofol provided a similar time for onset of sleep and muscle relaxation and required less time for successful intubation. 18 Another study with 21 term or preterm infants, with the aim to assess the effectiveness and safety of a combination of propofol (2 mg kg À1 ) and fentanyl (0.15 mg kg À1 ) to facilitate tracheal intubation, found a successful intubation rate at first attempt of 86% of the infants, and intubation was considered easy in all of them. 10 The authors emphasize the necessity to associate an opioid to propofol and also that the hypotension caused by the drug can be detrimental in patients with pulmonary hypertension. In our study, a similar rate of successful intubation at first attempt (80%) was found considering the association of propofol and remifentanil.
The benzodiazepine midazolam is water soluble, highly protein bound and, as an induction agent, has a slower onset of action than propofol.
14 This drug has not been widely studied as premedication for neonates and data are so far contradictory. 5, 8 It should also be pointed out that the incidence of successful intubation is directly related to the moment when the tracheal intubation is done and the plasma peak of the drugs used as premedication. 2 It may be an explanation for the different rates of successful intubation found in the previous study by Silva et al., 2 where 6 in 10 patients who received an association of remifentanil and midazolam had the intubation conditions assessed as excellent versus 3 in 10 patients in the present study. Regarding the complications related to premedication used here, hypotension (defined as mean arterial blood pressure <25 mm Hg) was found in two patients in each group in the first 30 min after premedication, but no signs of low perfusion were detected, and the episodes did not need to be treated. Only one patient in the propofol group had a transient bradycardia (HR ¼ 96) for <30 s. The ventilation of two patients in the propofol and one in the midazolam group was considered difficult. However, there was no desaturation in these three patients and the difficulty was transitory. A differential diagnosis should be done here between chest wall rigidity (all patients received remifentanil) and vocal cord closure. Previous studies did not find any case of chest wall rigidity. 2, 4 There is evidence suggesting that the difficult facemask ventilation that can occur during induction of anesthesia after the use of opioids over a short period of time is likely to be due to vocal cord closure, thus questioning the role of thorax/ truncal rigidity. 19 The small number of patients included in the study may be a concern. Although limited in size, our strict inclusion criteria, the use of randomization, the intubation and evaluation of the quality of intubation (made by just one person) have provided important preliminary information for future investigations.
In conclusion, our findings suggest that besides midazolam, propofol might be a valid alternative as hypnotic drug to the regimen of premedication for endotracheal intubation in neonates. It could have theoretical and practical advantages (fast onset and offset of action) and an acceptable pharmacodynamic profile. Further randomized controlled trial enrolling different centers are warranted to confirm our preliminary data. 
